$BCRX insider trading

Over the last 12 months, Biocryst Pharmaceuticals insiders reported no purchases and 7 sales totaling $6.1M across SEC Form 4 filings. 86% of those filings were made under pre-arranged 10b5-1 trading plans.

$6.1M
7
4
86%
Side
$1K$10K$100K$1.0M$10MJun '26JulAugNo insider events in this range
Barnes Alane P
SANDERS MACHELLE
HEGGIE THERESA
Stonehouse Jon P

All insider trades

Scroll the table sideways for price, value and marks.

Mar 20, 2026HEGGIE THERESA▼ Sale49,933$10.11$505K-43.3%
Mar 16, 2026Barnes Alane P▼ Sale150,000$9.15$1.4M-27.2%
Mar 2, 2026Stonehouse Jon P▽ Sale to issuer305,995$8.64$2.6M-18.8%
Dec 22, 2025Barnes Alane P▼ Sale21,773$7.65$167K-5.2%
Dec 15, 2025Barnes Alane P▼ Sale21,210$7.65$162K-6.3%
Dec 3, 2025Barnes Alane P▼ Sale161,680$7.21$1.2M-31.9%
Nov 13, 2025SANDERS MACHELLE▼ Sale9,600$7.14$69K-23.9%
Aug 13, 2025HEGGIE THERESA▼ Sale70,000$8.51$596K-51.7%

Every $BCRX filing on this page is one API call away

The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Biocryst Pharmaceuticals filings can reach your inbox instead.

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $BCRX feed.

BCRX Insider Trading — Biocryst Pharmaceuticals Form 4 Buys & Sells | alphai